Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedApr 16, 2014Pleo Nota- Quent DROPS 5XPenicillin Cross ContaminationTerra-Medica Inc. · D-1199-2014Class IITerminatedApr 16, 2014Pleo Not PORTABLE SIPS 7XPenicillin Cross ContaminationTerra-Medica Inc. · D-1198-2014Class IITerminatedApr 16, 2014Pleo Not PORTABLE SIPSPenicillin Cross ContaminationTerra-Medica Inc. · D-1197-2014Class IITerminatedApr 16, 2014Pleo Not PORTABLE SIPSPenicillin Cross ContaminationTerra-Medica Inc. · D-1196-2014Class IITerminatedApr 16, 2014Pleo Not DROPSPenicillin Cross ContaminationTerra-Medica Inc. · D-1195-2014Class IITerminatedApr 16, 2014Pleo Not TABLETS 5XPenicillin Cross ContaminationTerra-Medica Inc. · D-1194-2014Class IITerminatedApr 16, 2014Pleo Not CAPSULES 4XPenicillin Cross ContaminationTerra-Medica Inc. · D-1193-2014Class IITerminatedApr 16, 2014Pleo Not SUPPOSITORIES 3XPenicillin Cross ContaminationTerra-Medica Inc. · D-1192-2014Class IITerminatedApr 16, 2014Pleo Not OINTMENT 3XPenicillin Cross ContaminationTerra-Medica Inc. · D-1191-2014Class IIITerminatedApr 9, 2014QVAR¿ (beclomethasone dipropionate HFA)Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time pointTeva Pharmaceuticals USA · D-1190-2014Class IITerminatedApr 9, 2014HydrOXYzine HCl TabletsGood Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.American Health Packaging · D-1189-2014Class IITerminatedApr 9, 2014HydrOXYzine HCl TabletsGood Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.American Health Packaging · D-1188-2014Class IIITerminatedApr 9, 2014Suprax, Cefixime for Oral Suspension USPFailed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.Lupin Pharmaceuticals Inc. · D-1187-2014Class IIITerminatedApr 9, 2014Suprax, Cefixime for Oral Suspension USP 500 mg/5 mlFailed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.Lupin Pharmaceuticals Inc. · D-1186-2014Class IIITerminatedApr 9, 2014TivicayCross Contamination with Other Products: Product contains Promacta (eltrombopag).Viiv Healthcare Company · D-1185-2014Class IITerminatedApr 9, 2014Duloxetine Delayed-Release CapsulesFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a...Teva Pharmaceuticals USA · D-1184-2014Class IITerminatedApr 9, 2014Duloxetine Delayed-Release CapsulesFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a...Teva Pharmaceuticals USA · D-1183-2014Class IITerminatedApr 9, 2014Duloxetine Delayed-Release CapsulesFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a...Teva Pharmaceuticals USA · D-1182-2014Class IIITerminatedApr 2, 2014SETON PHARMACEUTICALS Fluocinolone Acetonide 0.01% Oil EAR DROPSSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1181-2014Class IIITerminatedApr 2, 2014SETON PHARMACEUTICALS Fluocinolone Acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1180-2014Class IIITerminatedApr 2, 2014SETON PHARMACEUTICALS Fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1179-2014Class IIITerminatedApr 2, 2014ROYAL PHARMACEUTICALS DermOtic Oil fluocinolone acetonide 0.01%Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1178-2014Class IIITerminatedApr 2, 2014ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01%Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1177-2014Class IIITerminatedApr 2, 2014ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1176-2014Class IIITerminatedApr 2, 2014Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1175-2014Class IIITerminatedApr 2, 2014Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1174-2014Class IIITerminatedApr 2, 2014DermOtic OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1173-2014Class IITerminatedMar 26, 2014DaytranaDefective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner...Noven Pharmaceuticals, Inc. · D-1172-2014Class IITerminatedMar 26, 2014DaytranaDefective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner...Noven Pharmaceuticals, Inc. · D-1171-2014Class ITerminatedMar 26, 2014Silver Sword capsulesMarketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active...Fabscout Entertainment, Inc · D-1170-2014Class ITerminatedMar 26, 2014Clalis capsulesMarketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active...Fabscout Entertainment, Inc · D-1169-2014Class IITerminatedMar 26, 2014Perrigo, Clindamycin Palmitate Hydrochloride for Oral SolutionPresence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.Paddock Laboratories, LLC · D-1168-2014Class IIITerminatedMar 26, 2014Venlafaxine HydrochlorideFailed Dissolution Specification: Out of Specification dissolution results at 12 month interval.McKesson Packaging Services · D-1167-2014Class IIITerminatedMar 26, 2014Advil PM CapletsSubpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.Pfizer Us Pharmaceutical Group · D-1166-2014Class IITerminatedMar 26, 2014Guaifenesin USPPresence of Foreign Matter: Guaifenesin API powder is being recalled due to the possibility that the product contains polyethylene fibers from a screen used to sift the...Traxx International Corp · D-1165-2014Class IITerminatedMar 26, 2014Hydroxyprogesterone Caproate 250mg/ml in Sesame OilCrystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during shippingRX South LLC DBA RX3 Pharmacy · D-1164-2014Class ITerminatedMar 26, 20140.9% Sodium Chloride InjectionPresence of Particulate Matter: Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and...Baxter Healthcare Corp. · D-1163-2014Class ITerminatedMar 26, 20145% Dextrose InjectionPresence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and...Baxter Healthcare Corp. · D-1162-2014Class ITerminatedMar 26, 2014MarcainePresence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.Hospira Inc. · D-1161-2014Class ITerminatedMar 26, 2014Clinimix 5/15 sulfite-freePresence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.Baxter Healthcare Corp. · D-1160-2014